Bacterial antigens and toxins

Bacterial antigens and toxins represent a broad class of molecules produced by bacteria that facilitate infection and cause direct or indirect damage to the host. Antigens, such as surface proteins and lipopolysaccharides (endotoxins), are recognized by the host immune system and are primary targets for vaccines and diagnostic assays (NIH, 2024). Toxins, primarily exotoxins, are secreted proteins that disrupt essential cellular processes like protein synthesis, signal transduction, or membrane integrity, leading to severe clinical manifestations such as toxic shock, paralysis, or sepsis (ASM, 2022). Therapeutic strategies targeting these molecules include monoclonal antibodies that neutralize specific toxins, such as bezlotoxumab for Clostridioides difficile toxin B and obiltoxaximab for Bacillus anthracis protective antigen (Drugs.com, 2024; NIH, 2024). Additionally, toxoid vaccines like those for tetanus and diphtheria utilize inactivated toxins to prime the immune system for long-term protection (StatPearls, 2023). Beyond direct neutralization, bacterial toxins are also being repurposed as therapeutic tools in oncology. For instance, immunotoxins like denileukin diftitox utilize the potent cytotoxic domains of diphtheria toxin to selectively kill cancer cells expressing specific receptors (ASM, 2022). This dual role as both a pathogen-derived threat and a potential therapeutic scaffold highlights the complex biological significance of this molecular class. Because this term encompasses a vast array of distinct molecular structures across many species, it is considered a functional grouping rather than a single, specific therapeutic target.

Other names

Bacterial virulence factorsBacterial exotoxinsBacterial endotoxinsPathogen-associated molecular patternsPAMPsBacterial protein toxins

Neutralization of toxin activity, inhibition of toxin binding to host cell receptors, prevention of toxin internalization, and induction of protective immune responses through opsonization or complement activation (NIH, 2024; ASM, 2022).